Reversible alopecia in Vogt-Koyanagi-Harada disease and sympathetic ophthalmia

11Citations
Citations of this article
13Readers
Mendeley users who have this article in their library.

This article is free to access.

Abstract

Background: Vogt-Koyanagi-Harada (VKH) disease and sympathetic ophthalmia (SO) are both autoimmune disorders targeting melanin-bearing cells, even though their etiologies are different. Both shared many ocular and systemic manifestations, including integumentary findings. Most of the literature focused on the ocular manifestations and related treatment. Alopecia was seldom mentioned. Findings: We report one case of VKH disease and one case of SO. Both developed severe alopecia and early sunset glow fundus, which are probably due to incomplete treatment. Fortunately, the alopecia improved soon after systemic steroid treatment. Conclusions: Early and complete treatments are important in the management of VKH or SO and prevent integumentary manifestation. Alopecia can be reversible after steroid treatment in time. © 2013 Chuang et al.

Cite

CITATION STYLE

APA

Chuang, C. T., Huang, P. S., Chen, S. C., & Sheu, S. J. (2013). Reversible alopecia in Vogt-Koyanagi-Harada disease and sympathetic ophthalmia. Journal of Ophthalmic Inflammation and Infection, 3(1), 1–5. https://doi.org/10.1186/1869-5760-3-41

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free